Resmed Introduces Sleep Institute with Focus on Enhancing Sleep Health on a Global Scale
Resmed, a leading health technology company, has announced the launch of Sleep Institute, a global clinical insights initiative dedicated to advancing sleep health. The initiative aims to act as a catalyst for earlier diagnosis, stronger policies, and improved outcomes in sleep health worldwide.
Sleep Institute partners with clinicians, researchers, policymakers, and health system leaders to deliver objective, non-commercial, evidence-based insights. The institute's focus is on translating evidence into action to aid clinicians, policymakers, and health systems in earlier detection and personalized care.
The majority of people with sleep disorders remain undiagnosed, leading to higher rates of chronic disease, lost productivity, and rising healthcare costs. Sleep Institute aims to address this gap by publishing original research, expert perspectives, and real-world data to support earlier and more accurate diagnosis.
Resmed's AI-powered digital health solutions, cloud-connected devices, and intelligent software make home healthcare more personalized, accessible, and effective. The company envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home.
The symposium titled "OSA Underdiagnosis - A world of difference, a common challenge" will debut at the World Sleep Congress. The symposium brings together clinical leaders from Iceland, Singapore, the United States, and Sweden, including Ludger Grote, medical director of the Sleep Disorders Center at Sahlgrenska University Hospital (Sweden), Michelle R. Zeidler, professor of medicine at the University of California, Los Angeles (UCLA) and director of the VA Greater Los Angeles Sleep Center (U.S.), Chi-Hang Ronald Lee, professor of medicine at the National University of Singapore and senior consultant at the National University Heart Centre and Alexandra Hospital (Singapore), and Erna Sif Arnardóttir, director of Reykjavik University Sleep Institute and president of the European Sleep Research Society (Iceland).
Michelle R. Zeidler emphasizes the urgent need for closing the diagnosis gap in sleep disorders like OSA. The study "Estimation of the global prevalence and burden of insomnia: a systematic literature review-based analysis," published in 2025, supports this claim, stating that sleep disorders, such as obstructive sleep apnea (OSA) and insomnia, are common health challenges affecting an estimated 1 billion people with OSA and 852 million adults with insomnia.
For media inquiries, contact Julia Moser at [email protected] or [email protected]. For investor relations, contact Salli Schwartz at [email protected] or [email protected]. Sleep Institute aims to help inform care model innovation, support policy development, and reinforce the vital role of sleep in improving health outcomes worldwide.
Read also:
- Understanding Hemorrhagic Gastroenteritis: Key Facts
- Stopping Osteoporosis Treatment: Timeline Considerations
- Tobacco industry's suggested changes on a legislative modification are disregarded by health journalists
- Expanded Community Health Involvement by CK Birla Hospitals, Jaipur, Maintained Through Consistent Outreach Programs Across Rajasthan
